Evidence map›Paper›PMID 35813692›Full record

ArticleCase reports in oncology

High-Grade Renal Mucinous Tubular and Spindle Cell Carcinoma.

Kyotaro Fukuta, Ryoichi Nakanishi, Takahiro Moriyama, Hirofumi Izaki, Takumi Kakimoto, Takeshi Oya, Tomoya Fukawa, Kunihisa Yamaguchi, Yasuyo Yamamoto, Masayuki Takahashi and 2 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Case reports in oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 5 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Kyotaro FukutaDepartment of Urology, Tsurugi Municipal Handa Hospital, Tsurugi, Japan.
Ryoichi NakanishiDepartment of Urology, Tokushima Prefectural Miyoshi Hospital, Miyoshi, Japan.
Takahiro MoriyamaDepartment of Urology, Tsurugi Municipal Handa Hospital, Tsurugi, Japan.
Hirofumi IzakiDepartment of Urology, Tokushima Prefectural Central Hospital, Tokushima, Japan.
Takumi KakimotoDepartment of Pathology and Laboratory Medicine, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
Takeshi OyaDepartment of Molecular Pathology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
Tomoya FukawaDepartment of Urology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
Kunihisa YamaguchiDepartment of Urology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
Yasuyo YamamotoDepartment of Urology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
Masayuki TakahashiDepartment of Urology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
Yasushi SutouDepartment of Urology, Tsurugi Municipal Handa Hospital, Tsurugi, Japan.
Hiro-Omi KanayamaDepartment of Urology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
Tokushima University · JPTsurugi Hospital · JPTokushima Prefectural Central Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mucinous tubular and spindle cell carcinoma (MTSCC) is a rare subtype of renal cell carcinoma. Although usually indolent, high-grade MTSCC has been reported to exhibit an aggressive clinical course. Herein, we report a case of high-grade renal MTSCC. An 86-year-old man visited our hospital with fever and fatigue. Based on contrast-enhanced computed tomography findings, the patient was diagnosed with clinical stage T2aN0M0 right renal cell carcinoma and underwent laparoscopic radical nephrectomy. Histological examination showed tubular to tubulopapillary structures accompanied by mucinous stroma, suggesting high-grade renal MTSCC. He remained recurrence- and metastasis-free 6 months after nephrectomy. Since high-grade renal MTSCC may have an aggressive clinical course, such patients should be observed carefully after radical nephrectomy.

Indexed as

Radical nephrectomyRenal cell carcinomaRenal mucinous tubular and spindle cell carcinoma

Identifiers

PMID35813692
PMCPMC9209964
OpenAlexW4281718063

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.